Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NiCord Co-Transplantation Pilot Study
NCT01221857Phase 2Completed
- Sponsor
- Gamida Cell
- Start
- Nov 2010
- Primary completion
- Sep 2012
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of omidubicel in acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), non-Hodgkin lymphoma (NHL), Hodgkin lymphoma (HL), sponsored by Gamida Cell. Started Nov 2010; status: completed.
02
Drugs
omidubicel
03
Conditions
acute lymphoblastic leukemia (ALL)acute myeloid leukemia (AML)myelodysplastic syndrome (MDS)non-Hodgkin lymphoma (NHL)Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT01221857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01221857.